Form D · Biotechnology
Circinus Medical Technology LLC
Concord, MA · CIK 0001815322
Offering snapshot reported Aug 4, 2026 · SEC filing
- Reported sold
- $4.24M Offering amount: $5M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2026 | Initial | $4,239,497 | No comparison | 11 | SEC filing |
| Feb 9, 2024 | Amendment | $6,925,563 | $1,099,977vs Jan 17, 2024 | 11 | SEC filing |
| Jan 17, 2024 | Initial | $5,825,586 | No comparison | 10 | SEC filing |
| Dec 10, 2021 | Initial | $2,250,035 | No comparison | 1 | SEC filing |
| Jun 18, 2020 | Initial | $590,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593112
Source: Form D, filed Aug 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Bonadio | Director |
| David Bovenzi | Director |
| John Dorman | Director |
| Mathew Ray | Director |
| Matthew Ray | Director |
| Patrick West | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 7 Domino Dr.
Concord, MA, 01742
Phone: 866-628-3422
Concord, MA, 01742
Phone: 866-628-3422